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TGFb1 Inhibits NF-kB/Rel Activity
Inducing Apoptosis of B Cells:
Transcriptional Activation of IkBa
Marcello Arsura, Min Wu, oligonucleotides against c-myc to immature T cells and
some T cell hybridomas prevented T cell receptor–and Gail E. Sonenshein
Department of Biochemistry mediated apoptosis (Shi et al., 1992). In contrast, the
evidence in immature B cell models of tolerance, such asBoston University School of Medicine
Boston, Massachusetts 02118 WEHI 231 and CH31 and CH33 cells (Boyd and Schrader,
1981; Kim et al., 1979; Monroe and Seyfert, 1988; Ralph,
1979), has correlated the drop in c-Myc expression with
induction of apoptosis. An early transient increase fol-Summary
lowed by a dramatic decline in levels of c-myc RNA and
protein precedes anti-immunoglobulin receptor–TGFb1 treatment of B cell lymphomas decreases
mediated induction of apoptosis of WEHI 231 and CHc-myc gene expression and induces apoptosis. Since
31 B cells (Ales-Martinez et al., 1988; Benhamou et al.,we have demonstrated NF-kB/Rel factors play a key
1990; Hasbold and Klaus, 1990; Levine et al., 1986;role in transcriptional control of c-myc, we explored
Maheswaran et al., 1991; McCormack et al., 1984). Inthe effects of TGFb1 on WEHI 231 immature B cells.
WEHI 231 and CH 33 cells stably transfected to expressA reduction in NF-kB/Rel activity followed TGFb1
an immunoglobulin D (IgD) surface molecule, both anti-treatment. In WEHI 231 and CH33 cells, we observed
IgM and anti-IgD treatments led to transient increasesan increase in IkBa, a specific NF-kB/Rel inhibitor, due
of c-myc expression, but only anti-IgM caused a declineto transcriptional induction. Engagement of surface
in c-myc RNA levels below baseline followed by apop-CD40 or ectopic c-Rel led to maintenance of NF-kB/
tosis, whereas anti-IgD treatment maintained c-myc ex-Rel and c-Myc expression and protection of WEHI 231
pression at or above control levels and no induction ofcells from TGFb1-mediated apoptosis. Ectopic c-Myc
apoptosis was noted (Tisch et al., 1988; Ales-Martinezexpression overrode apoptosis induced by TGFb1.
et al., 1988). Similarly, mutants of WEHI 231 that failedThus, downmodulation of NF-kB/Rel reduces c-Myc
to induce apoptosis in response to anti-immunoglobulinexpression, which leads to apoptosis in these imma-
displayed sustained c-myc expression (Hibner et al.,ture B cell models of clonal deletion. The inhibition of
1994). Furthermore, addition of c-myc antisense oligo-NF-kB/Rel activity represents a novel TGFb signaling
nucleotides prevented anti-immunoglobulin receptormechanism.
and TGFb1-mediated apoptosis in the murine WEHI 231
and CH31 cell lymphomas (Fischer et al., 1994); how-
ever, the treatment with c-myc antisense oligonucleo-Introduction
tide, butnot the mismatched control, led to the stabiliza-
tion of c-Myc protein and to protection againstThe transforming growth factor-b1 (TGFb1) exerts its
apoptosis.growth inhibitory properties on several cell types, in-
Previously, we identified two kB elements within thecluding B lymphoid cells (Massague`, 1990; Roberts and
murine c-myc gene, termed the upstream and internalSporn, 1990; Stavnezer, 1996). Treatment of murine im-
regulatory elements, URE and IRE, respectively (Duyaomature B cell lymphomas, such as WEHI 231 and CH31,
et al., 1990; Kessler et al., 1992b), which regulate c-mycwith TGFb1 leads to a block at the G1/S transition, fol-
expression (Duyao et al., 1992; Kessler et al., 1992a; Lalowed by apoptosis (Warner et al., 1992; Fischer et al.,
Rosa et al., 1994). Classical NF-kB is a heterodimeric1994). More recently, it has been demonstrated that
transcription factor formed of two subunits, NFKB1 (p50)TGFb1 treatment causes apoptosis in normal human B
and RelA (p65) (Ghosh et al., 1990; Kieran et al., 1990;cells and in Epstein–Barr virus (EBV)-negative lym-
Ruben et al., 1991; Nolan et al., 1991). Other membersphoma B cell lines (Chaouchi et al., 1995; Lomo et al.,
of the NF-kB/Rel family expressed in mammals include1995). It has beenproposed that TGFb1 exerts its growth
the proto-oncogene c-Rel, NFKB2 (p52), and RelB (Gil-inhibitory effects through the down-regulation of the
more, 1991; Neri et al., 1991; Schmid et al., 1991; Ryseckactivity of genes involved in cellular proliferation such
et al., 1992; Bours et al., 1992). The Rel family of factorsas cyclin-dependent kinases (Howe et al., 1991; Ewen et
is involved in the regulation of a diverse group of genesal., 1993; Hannon and Beach, 1994), the retinoblastoma
that play important roles in immune, acute phase, andsusceptibility product (pRb) (Laiho et al., 1990; Pietenpol
inflammatory responses, cell proliferation, and differen-et al., 1990) and the c-myc proto-oncogene (Coffey et
tiation (Grilli et al., 1993; Baeuerle and Henkel, 1994).al., 1988; Pietenpol et al., 1990). For example, TGFb1-
Furthermore, evidence indicates these factors mediateinduced apoptosis of WEHI 231 or CH31 cells is pre-
signals in immunoglobulin gene rearrangement (Kent-ceded by a decline in c-myc expression (Warner et al.,
ner et al., 1993). Rel factors are ubiquitously expressed1992; Fischer et al., 1994).
in most non-B cells as inducible dimeric complexesThe c-myc gene has been strongly implicated in the
(Baeuerle, 1991), sequestered in the cytoplasm by aregulation of cellular death. Overexpression or inap-
family of inhibitor proteins, termed IkBs, that includespropiate expression of the c-myc gene promoted apop-
IkBa and IkBb (Baeuerle and Baltimore, 1988; Davis ettosis in myeloid and fibroblast cells upon removal of
al., 1991; Haskill et al., 1991; Thompson et al., 1995). Afactors required for cell proliferation (Askew et al., 1991;
Evan et al., 1992). Furthermore, addition of antisense wide range of stimuli promotes nuclear translocation of
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Rel factors by a mechanism that involves phosphoryla-
tion and ubiquitination of these IkB proteins (reviewed
by Grilli et al., 1993; Verma et al., 1995).
Exponentially growing WEHI 231 cells express pre-
dominantly p50/c-Rel complexes and minor amounts
of classical NF-kB (p50/RelA) (Rice and Ernst, 1993;
Miyamoto et al., 1994; Liou et al., 1994; Lee et al., 1995).
Recently, we demonstrated that both basal and anti-
immunoglobulin–modulated c-myc gene expression in
WEHI 231 cells are controlled in large part by NF-kB/
Rel binding (Lee et al., 1995). Anti-immunoglobulin treat- Figure 1. TGFb1 Treatment Inhibits NF-kB/Rel Binding Activity in
ment led to a significant early transient induction of WEHI 231 Cells
binding and activity of NF-kB/Rel species followed by Equal amounts of nuclear extracts (5 mg protein), prepared from
WEHI 231 cells in exponential growth (E) and following treatmenta loss of binding below basal levels at later timepoints;
with 2 ng/ml TGFb1 cells for 3 or 6 hr, were used in EMSA withthese changes paralleled the increases and decreases
radiolabeled DNA fragments containing (left) the kB element up-in c-myc gene transcription (Lee et al., 1995). Here, we
stream of the murine c-myc promoter (URE), or (right) the internal
investigated the possible role of NF-kB/Rel factors in regulatory region (IRE) within exon 1 of the murine c-myc gene. The
mediating the effects of TGFb1 in WEHI 231 and CH33 six URE complexes are as follow: band 1, p50 homodimer; band 2,
cells. We found that TGFb1 treatment of WEHI 231 cells p50/c-Rel; band 3, p50/RelA; band 4, p50 and an unidentified sub-
unit; band 5, c-Rel homodimer, band 6, unidentified (Lee et al., 1995).decreased NF-kB/Rel binding activity. This decrease
The four IRE nucleoprotein complexes are as follows: band 1, p50could be related, inpart, to elevated levels of IkBa mRNA
homodimer; band 2, p50/c-Rel; band 3, p50/RelA; band 4, c-Reland protein resulting from increased transcription of the
homodimer (Schauer et al., 1996).
IkBa gene in both lines. Ablated apoptosis of WEHI 231
cells was observed with TGFb1 upon costimulation with
a soluble form of the CD40 ligand (CD40L), which led
5); furthermore, only much more minor alterations ob-tomaintained NF-kB/Rel and c-Myc expression, or upon
served in the binding activity of AP-1 complexes con-ectopic expression of c-Rel or c-Myc. These results
firmed the specificity of these changes (data not shown;indicate inhibition of NF-kB/Rel downmodulates c-Myc
see Figure 5). Thus, TGFb1 selectively reduces NF-kB/expression inducing death of these B cells, and dem-
Rel binding.onstrate a novel signaling pathway for TGFb1 through
NF-kB/Rel that has potential implications for multiple
TGFb1 Induces IkBa Synthesisprocesses within the immune system in addition to
The observed inhibition of NF-kB activity prompted usapoptosis, including activation of cell proliferation, dif-
to explore the possibility of induction upon TGFb1 treat-ferentiation, and gene rearrangement.
ment of IkBa, an inhibitor protein of NF-kB/Rel capable
of sequestering these dimeric species in the cytosolic
compartment (Baeuerle, 1991; Verma et al., 1995). Cyto-Results
plasmic extracts were isolated from WEHI 231 cells
treated with TGFb1 for 0, 3, 6, and 9 hr, and subjectedTGFb1 Down-Regulates NF-kB/Rel Activity
to immunoblot analysis. TGFb1 treatment led to induc-To determine whether TGFb1 treatment can alter NF-
tion of IkBa protein levels after 3 hr, and levels continuedkB/Rel activity, WEHI 231 cells were cultured in the ab-
to increase throughout the time course (Figure 2A). Thesence or presence of 2 ng/ml TGFb1 for 3 and 6 hr and
effect of TGFb1 was selective for the IkBa product, innuclear extracts prepared. Electrophoretic mobility shift
that IkBb protein remained constant throughout the 9analysis (EMSA) was performed with fragments con-
hr period (data not shown).taining the two kB sites within the c-myc gene, termed
IkBa protein in WEHI 231 cells is normally labile withthe URE and IRE (Duyao et al., 1990; Kessler et al.,
a half-life of approximately 30 min (Miyamoto et al.,1992b). As expected, nuclear extracts from untreated
1994). To test for stabilization of IkBa protein, WEHI 231WEHI 231 displayed several constitutivespecific binding
cells were treated with the protein synthesis inhibitorcomplexes with the URE (Figure 1, left) and IRE (Figure
cycloheximide (CHX) in the presence or absence of1, right) (Lee et al., 1995; Schauer et al., 1996). Previous
TGFb1. Cytoplasmic extracts were monitored by immu-EMSA supershift studies have identified the five fastest
noblotting for IkBa expression (Figure 2B). IkBa dis-migrating complexes with the URE as follows: band 1,
played the normal rapid rate of decay following TGFb1p50 homodimer; band 2, p50/c-Rel; band 3, p50/Rel
treatment. In addition, a similar decay of the IkBa proteinA; band 4, heterodimer containing p50 and an as yet
was observed when the cells were incubated for 6 hrunidentified partner; band 5, c-Rel homodimer; band 6,
with TGFb1 prior to CHX treatment (data not shown).unidentified (Lee et al., 1995; data not shown). For the
Thus, TGFb1 does not stabilize IkBa protein.fragment containing the IRE, the three fastest migrating
complexes are identical to those with the URE and the
fourth as a homodimer of c-Rel (Schauer et al., 1996). TGFb1 Induces IkBa mRNA Synthesis
To determine whether the increased protein expressionA slight decrease in binding was detectable by 3 hr of
TGFb1 treatment, and by 6 hr overall NF-kB/Rel binding was due to increased steady-stateRNA levels, the effect
of TGFb1 treatment on IkBa mRNA was measured. Afterto both the URE and IRE was significantly reduced. This
is more dramatically seen by 9 hr of TGFb1 treatment, 3 hr of TGFb1 treatment, an approximately 2.5-fold in-
duction in IkBa mRNA level was detected, and the levelin a separate experiment, illustrated below (see Figure
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Figure 2. TGFb1 Treatment Increases IkBa Expression in WEHI 231
and CH33 Cells
(A) TGFb1 increases IkBa protein levels in the cytoplasm of WEHI
231 cells. Cytoplasmic protein was isolated from cells in exponential
growth (E) or following TGFb1 treatment for the indicated timepoints
(hr) and subjected to immunoblotting using a polyclonal antibody
against IkBa. Based on molecular mass markers, the IkBa band has
a molecular mass of 38 kDa.
(B) TGFb1 treatment does not lead to IkBa protein stabilization in
Figure 3. TGFb1 Induces the IkBa mRNA Levels but Does Not AlterWEHI 231 cells.
the Stability of the Transcript in WEHI 231 Cells(C) Cells in exponential growth (E) were treated with 10 mg/ml CHX
in the absence or presence of TGFb1 (T). Cytoplasmic extracts, (A) TGFb1 increases steady-state levels of IkBa RNA. WEHI 231
isolated after 0.5, 1, or 1.5 hr of treatment, were analyzed by immu- cells in exponential growth (E) were exposed to TGFb1 for 2, 3, 6,
noblotting for IkBa. or 12 hr. Total RNA was isolated and subjected to Northern blot
(C) TGFb1 increases IkBa protein levels in the cytoplasm of CH33 analysis for expression of IkBa and GAPDH, as control for equal
cells. Exponentially growing CH33 cells (E) were incubated in the loading.
presence of TGFb1 for 9 and 20 hr, and cytoplasmic extracts (B) TGFb1 treatment does not alter the stability of IkBa mRNA.
analyzed by immunoblotting for IkBa and IkBb proteins, as above. Following treatment of WEHI 231 cell cultures for 9 hr with TGFb1
The band corresponding to IkBb protein has a molecular mass of (T) or carrier BSA (B), as control, 25 mg/ml DRB was added and total
49 kDa. RNA isolated after 0, 0.5, 1, and 2 hr. Northern blot analysis was
performed for mRNA expression of IkBa. Ethidium bromide staining,
used to confirm RNA integrity and equal loading of the samples, is
shown in the bottom panel.remained elevated for up to 12 hr (Figure 3A). Equal
loading of RNA samples was demonstrated by rehybrid-
ization of the same filter for the housekeeping gene
glyceraldehyde-3-P-dehydrogenase (GAPDH). We next Nuclei were isolated from exponentially growing WEHI
231 cells or following treatment with TGFb1 for 2.5 hr. Adetermined whether an increase in the half-life of the
IkBa mRNA could account for the increase in transcript significant increase in the rate of IkBa gene transcription
was detected at the 2.5 hr timepoint (Figure 4, left),level upon TGFb1 exposure, using 5, 6-dichlorobenzimi-
dazole riboside (DRB), a selective inhibitor of RNA poly- consistent with the observed induction of mRNA levels
at 3 hr. Densitometric scanning of this and a duplicatemerase II. Control and WEHI 231 cells that had been
treated with TGFb1 for 9 hr were incubated with 25 mg/ experiment gave an average fold increase of 3.1 6 0.36
when normalized to b-actin. In contrast, no effect onml DRB and total RNA was isolated at various timepoints
(Figure 3B). A t1/2 of approximately 30 min was observed pMT2T, the parental vector for the IkBa clone or pUC19
plasmid DNA was detectable, which suggests equalin control cells (Figure 3B). The IkBa mRNA levels de-
cayed in response to DRB treatment with the same kinet- RNA loading (Figure 4, left). Similarly, the rate of tran-
scription of b-actin and Max, the c-Myc binding partner,ics in the TGFb1-treated cultures. An induction of the
steady-state levels of IkBa mRNA levels was seen in was unaffected by TGFb1 treatment, consistent with the
lack of change in their mRNA levels over the time courseresponse to TGFb1 treatment (Figure 3B), as expected.
Thus, TGFb1 does not stabilize the normally labile IkBa (data not shown). Thus, an increase of IkBa gene tran-
scription following TGFb1 treatment appears responsi-mRNA from decay.
Totest whether TGFb1 increased the rate of IkBa gene ble for the increase of IkBa steady-state mRNA and
protein levels in the WEHI 231 cell line.transcription, nuclear run-on analysis was performed.
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Figure 4. TGFb1 Treatment of WEHI 231 and CH33 Cells Increases
the Rate of IkBa Gene Transcription
Nuclei were isolated from (left) WEHI 231 or (right) CH33 cells in
exponential growth or following treatment with TGFb1 for 2.5 hr and
subjected to run-on analysis. The radiolabeled RNA products were
analyzed with double-stranded DNA corresponding to the human
IkBa, rat b-actin, and murine Max genes. pMT2T and pUC19 DNA
was used as a measure of nonspecific hybridization.
TGFb1 Induces IkBa Gene Expression
in the CH33 Cell Line
To test whether TGFb1-mediated induction of IkBa gene
was unique to the WEHI 231 cell line or more general
to other immature B cell lymphomas, the CH33 cell line
was similarly analyzed. Following 20 hr of TGFb1 treat-
ment, CH33 cells display extensive DNA laddering
(Fischer et al., 1994; data not shown). Cytoplasmic ex-
tracts were isolated from CH33 cells treated with 2 ng/
ml TGFb1 for 9 and 20 hr and analyzed by immunoblot-
ting for IkBa protein. Treatment for 9 hr with TGFb1
led to an increase in IkBa protein levels that persisted
throughout the timecourse (see Figure 2C). TGFb1 treat-
Figure 5. CD40L Prevents TGFb1-Driven Apoptosis and Inhibitionment did not affect IkBb expression (see Figure 2C). We
of NF-kB/Rel Binding in WEHI 231 Cellsnext sought to evaluate whether TGFb1 increased the
(A) CD40L prevents TGFb1-driven apoptosis. WEHI 231 cells in ex-rate of IkBa gene transcription in CH33 cells (Figure
ponential growth (lane 1) were treated with BSA (lane 2) or TGFb1
4, right). A 2.1-fold increase in the rate of IkBa gene alone (lane 3) or in combination of CD40L and CD8a (CD40L) (lane
transcription, normalized to b-actin, was measured in 4), and analyzed for apoptosis after 20 hr using DNA fragmentation
nuclear run-on analysis at the 2.5 hr timepoint, similar assay. M, 123 marker DNA.
(B) CD40L prevents TGFb1-mediated down-regulation of NF-kB/Relto the results with WEHI 231 cells. As seen above, TGFb1
binding activity. Nuclear extracts were isolated from untreated WEHItreatment had no detectable effect on b-actin or Max
231 cells (E) or following treatment with TGFb1 alone (T) or in combi-gene expression or on hybridization to plasmid DNA,
nation with CD40L (T 1 CD40L) for 3, 6, and 9 hr. Samples (5 mg)
used as controls for equal loading (Figure 4, right). Thus, were subjected to EMSA using the IRE kB element, described in
TGFb1 selectively induces IkBa gene expression in mu- the legend to Figure 1. The specificity of the changes in binding
rine B cell lymphomas. activity was confirmed using EMSA with a radiolabeled AP-1 oligo-
nucleotide.
CD40 Ligand Prevents TGFb1-Driven Apoptosis
and Induces NF-kB/Rel Levels Recently, we have observed that CD40L treatment of
The observation that engagement of surface CD40, a WEHI 231 cells caused an increase in NF-kB/Rel binding
member of the tumor necrosis factor receptor (TNFR) and prevented the decline following anti-immunoglobu-
superfamily (Banchereau et al., 1994), was sufficient to lin treatment (Schauer et al. 1996). Costimulation with
neutralize the anti-immunoglobulin–mediated apoptosis CD40L similarly reversed thedecrease innuclear extract
of WEHI 231 cells (Tsubata et al., 1993) prompted us to binding to the IRE mediated by TGFb1 (Figure 5B). In
ask whether CD40L treatment could similarly override addition, CD40L appeared to abrogate the changes in
TGFb1-driven apoptosis. WEHI 231 cells were treated AP-1 binding induced by TGFb1. As expected, the
for 20 hr with TGFb1 alone or together with CD40L, and TGFb1-mediated drop in kB binding could be related to
apoptosis measured by DNA fragmentation analysis. As a decrease in nuclear levels of RelA and c-Rel protein
seen in Figure 5A, the extensive DNA laddering induced (Figure 6A). In contrast, costimulation with TGFb1 and
by TGFb1 treatment was prevented upon costimulation CD40L up-regulated their expression. We next exam-
ined the effects of costimulation with CD40L on thewith CD40L.
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overall induction of c-myc expression (data not shown).
To confirm the RNA was functional, the effects on c-Myc
protein expression were monitored. Nuclear protein ex-
tracts of WEHI 231 cells, treated with TGFb1 for the
indicated times in the absence or presence of CD40L,
were subjected to immunoblot analysis. As expected,
within 6 hr of TGFb1 treatment alone, a decline in c-Myc
nuclear protein levels was observed (Figure 6A), consis-
tent with kinetics of the drop in c-myc mRNA levels
(Warner et al., 1992; data not shown). The combined
treatment of TGFb1 and CD40L led to an increase in
c-Myc protein levels that were maintained above basal
levels for up to 9 hr (Figure 6A). Thus, CD40L costimula-
tion leads to the maintenance of elevated levels of c-myc
expression.
Since sustained c-myc expression correlated directly
with Rel-related factor activity, we tested for theability of
ectopic expression of c-Rel to modulate c-Myc protein
levels. Transfected WEHI 231 cells were selected with
G418 following electroporation with murine c-relexpres-
sion vector (La Rosa et al., 1994) and pSV2neo, as de-
scribed previously (Wu et al., 1996), or pSV2neo alone,
as control. Two stable WEHI 231 c-Rel transfectant
clones, Rel 12 and Rel 63, and one control pSV2neo
transfectant clone (NEO 5) were characterized by immu-
Figure 6. Maintenance of Nuclear NF-kB/Rel Activity Resulting from noblotting for their levels of nuclear c-Rel protein follow-
CD40L Treatment or Ectopic Expression of c-Rel Ablates TGFb1- ing TGFb1 treatment. Rel 12 and Rel 63 retained c-Rel
Driven Drop in c-Myc Expression
expression for up to 12 hr, whereas the NEO 5 control
(A) CD40L treatment overrides TGFb1 downmodulation of NF-kB/ cells showed marked down-regulation of c-Rel levelsRel and c-Myc expression in WEHI 231 cells. Nuclear and cyto-
(data not shown). Whenthese same nuclear lysates wereplasmic protein was isolated from WEHI 231 cells in exponential
analyzed for c-Myc expression, Rel 12 and Rel 63 weregrowth (E) or following treatment with either TGFb1 alone (T) or in
combination with CD40L (T 1 CD40L) for 3, 6, or 9 hr. Samples (40 found to maintain c-Myc protein levels following TGFb1
mg) were subjected to immunoblot analysis, using antibody prepara- treatment, whereas the expected decline was noted in
tions against c-Myc, c-Rel, RelA, and IkBa. The doublet correspond- NEO 5 cells (Figure 6B). These clones were next tested
ing to c-Myc has a molecular mass of 67/69 kDa. for their sensitivity to TGFb1-mediated apoptosis. Com-
(B) Ectopic expression of c-Rel ablates the decrease in nuclear
pared with the NEO 5 cells, both the Rel 12 and Rel 63c-Myc protein levels. WEHI 231 stable transfectant lines, prepared
clones displayed more extensive survival and prolifera-with either pSV2neo vector (NEO) alone or with the murine c-Rel
expression vector (Rel 12, Rel 63), were incubated for 12 hr in the tion even after 48 hr of TGFb1 treatment, as judged by
presence of BSA (B) or TGFb1 (T). Samples of nuclear proteins cell numbers (data not shown) and trypan blue exclu-
(20 mg) were subjected to immunoblotting using an affinity-purified sion. The values for the percentage of trypan blue–
c-Myc antibody. positive (dead) cells, determined in triplicate cultures,
were 12.8 6 1.6% for Rel 12, 10.5 6 2.0% for Rel 63,
and 35.9 6 1.4% for NEO 5. Lastly, to confirm that the
induction of IkBa protein levels upon TGFb1 treatment cells retained TGFb1 responsiveness, the induction in
(Figure 6A). TGFb1 treatment alone resulted in an in- IkBa protein expression was confirmed following 12 hr
crease above baseline of cytoplasmic levels of IkBa, of TGFb1 treatment (data not shown). Thus, c-Rel ex-
as seen above. This increase was reversed by CD40L pression leads to elevated c-Myc expression and rescue
treatment in combination with TGFb1. In fact, a dramatic from apoptosis following TGFb1 treatment.
decrease of IkBa protein levels well below baseline val-
ues was observed, suggesting signals regulating ex-
pression of the inhibitor protein induced by CD40L over- Ectopic Expression of c-Myc Overrides
rode those of TGFb1 (Figure 6A). Thus, an increase in TGFb1-Driven Apoptosis of WEHI 231 Cells
overall nuclear NF-kB/Rel binding was induced by To test directly the role of CD40L-mediatedmaintenance
CD40L, which could be correlated, at least in part, with of c-Myc on apoptosis of WEHI 231 cells induced by
a decrease in IkBa expression. TGFb1, the effects of ectopic expression of c-myc were
monitored. Stable transfectants were prepared with the
human c-myc expression vector pM21 (Stone et al.,CD40L or Ectopic Expression of c-Rel
Maintains c-Myc Expression 1987), and assayed by immunoblotting for c-Myc ex-
pression. The pM21 clones displayed normal levels ofTo assess whether the changes in NF-kB/Rel activity
results in altered c-myc gene expression, RNA was iso- c-Myc protein when compared with the pSV2neo stable
clones (Figure 7A; data not shown). Following TGFb1lated and analyzed by reverse transcription polymerase
chain reaction. The reduction below baseline of c-myc treatment of the pM21 clone P17, an elevated level of
c-Myc protein was retained for up to 20 hr. These find-mRNA levels after 20 hr of TGFb1 treatment was re-
versed by costimulation with CD40L, resulting in an ings are in marked contrast with the down-regulation of
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compared with carrier bovine serum albumin (BSA) (Fig-
ure 7B, inset). These results indicate that the mainte-
nance of c-Myc levels, mediated by ectopic expression
or CD40L, is sufficient to override the effects of TGFb1
treatment on viability of WEHI 231 cells.
Bcl-xL but not Bcl-2 has been found to inhibit anti-
immunoglobulin–mediated apoptosis of WEHI 231 cells
(Gottschalk et al.,1994). A constitutive Bcl-xL expressing
WEHI 231 cell line (JMBCLX) displayed significant resis-
tance to apoptosis induced by TGFb1 treatment (Figure
7B). Interestingly, expression of Bcl-xL did not counter-
act the growth arrest induced by TGFb1 exposure (data
not shown). Thus, expression of Bcl-xL overrides the
signal promoting apoptosis induced by TGFb1; its action
appears to be mediated further downstream within the
apoptosis cascade.
Discussion
In this study, we have shown a novel signaling pathway
for TGFb1 via a decrease in NF-kB/Rel activity. An induc-
tion of IkBa protein levels and gene transcription was
mediated by TGFb1 treatment. The reduction in NF-
kB/Rel binding correlated with a drop in c-Myc levels.
Costimulation with CD40L neutralized the TGFb1-medi-
ated effects and resulted in the induction and mainte-
nance of NF-kB/Rel activityand c-Myc expression. Simi-
larly, ectopic expression of c-Rel led to sustained levels
of c-Myc following TGFb1 treatment. Both treatment
with CD40L and ectopic c-Rel expression, as well as
ectopic expression of c-Myc, led to protection from
TGFb1-driven apoptosis. These results indicate a com-
mon pathway for induction of physiologic cell death ofFigure 7. Ectopic Expression of c-Myc Prevents Apoptosis of WEHI
immature B cells by TGFb1 and anti-immunoglobulin: a231 Cells Induced by TGFb1
drop in NF-kB/Rel activity that results in a drop in c-myc(A) Stable transfectants retain high levels of c-Myc expression fol-
expression. In agreement with these findings, we havelowingTGFb1 treatment. Stable transfectant lines of WEHI 231 cells,
prepared with either pSV2neo alone (NEO) or with the pM21 c-myc found that forced down-regulation of c-Myc/Max activ-
expression vector (P17), were incubated in the absence (E) or pres- ity via overexpression of Mad led to the induction of
ence of TGFb1 for 9 and 20 hr. Nuclear proteins (40 mg) were sub- apoptosis of WEHI 231 cells (M. W. et al., submitted).
jected to immunoblotting for c-Myc, as above.
Thus, the drop of c-Myc expression, rather than its over-(B) Ectopic expression of c-Myc prevents apoptosis upon TGFb1
expression, appears responsible for the signaling thatexposure. Two stable c-Myc WEHI 231 clones (P17 and P35) or
triggers the initiation of apoptosis of these immaturecontrol Neo cells were treated with TGFb1 for 20 hr, and subjected
to the DNA fragmentation assay of apoptosis. Alternatively, a stable B cells. Two major regulatory mechanisms have been
WEHI 231 line expressing Bcl-xL (JMBCLX) was similarly analyzed. identified for deletion of autoreactive B cells: physical
M, 123 marker DNA. Inset, TGFb1 treatment leads to induction of deletion and functional inactivation of self-reactive B
IkBa RNA levels in the c-Myc lines. RNA was isolated from the P17
cells, termed clonal deletion and anergy, respectivelyand P35 c-Myc and Neo control clones, treated for 9 hr with TGFb1
(reviewed by Nossal, 1994). It has been postulated that(T) or BSA (B), as control, and samples (20 mg) were analyzed for
clonal deletion plays a major role during normal B cellIkBa levels.
development (Nossal, 1994). Our findings with the WEHI
231 and CH 33 lines, widely used as models for clonalc-Myc observed in the control NEO 5 cells (Figure 7A)
deletion, suggest that Rel-related factors and c-mycand in the parental WEHI 231 cells (see Figure 6A). We
play major roles in mediating the signals leading to Bnext tested two of the c-Myc clones, P17 and P35, for
cell death, as well as rescue via CD40L.their sensitivity to apoptosis following TGFb1 treatment.
A significant protection from apoptosis, as judged by
the absence of DNA fragmentation, was observed. The TGFb1 Signals Through NF-kB/Rel
TGFb1 acts as a pleiotropic immunosuppressant factorNEO 5 cells remained sensitive to TGFb1-driven apop-
tosis (Figure 7B). In addition, the pM21 clones displayed through inhibition of B and T cell function, including
inhibition of secretion of lymphokines and activationextensive survival and were proliferating even after 48
hr of TGFb1 treatment (data not shown). The P17 and of cell proliferation (Massague`, 1990; Stavnezer, 1996).
Further, TGFb1-deficient mice presented severe dys-P35, as well as control NEO 5 cells, retained TGFb1
responsiveness, as judged by the increase in IkBa gene function in immune and inflammatory systems such that
massive inflammatory cell infiltration in several organsexpression following incubation for 9 hr with TGFb1
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and abnormal production of interferon g, TNFa, and WEHI 231 cells (Wu et al., 1996). Lastly, microinjection
of an IkBa–GST protein, and not control GST protein,MIP1a were noted (Shull et al., 1992). Among its immu-
nosuppressant activities, TGFb1 has been implicated in induced apoptosis of WEHI 231 cells. Taken together,
our data strongly suggest that apoptosis of B cells isthe induction of apoptosis in several B cells (Rotello et
al., 1991; Oberhammer et al., 1992). In particular TGFb1 promoted by down-regulation of NF-kB/Rel; further-
more, they lead to the prediction that a similar mecha-induced apoptosis of murine and human B cell lympho-
mas and of normal human B cells (Warner et al., 1992; nism may apply with other agents, e.g., dexamethasone,
that similarly reduce Rel factor activity.Chaouchi et al., 1995; Lomo et al., 1995). Our finding
that TGFb1 stimulation leads to a downmodulation of NF-kB/Rel species have been implicated in the regula-
tion of B lymphocyte apoptosis by other groups. Trans-NF-kB/Rel activity suggests that investigation of the
possible role of this family of factors in many of the formation of bursal lymphocytes by v-Rel protected
these cells from apoptosis induced by follicular disper-observed immunosuppressant effects of TGFb1 is now
needed. Furthermore, we have observed that phorbol sion or by exposure to g radiation (Neiman et al., 1991).
Similarly, Gilmore and coworkers demonstrated thatester–mediated activation of NF-kB/Rel in WEHI 231
cells is blocked by TGFb (M. A. and G. E. S., unpublished chicken splenic lymphocytes, transformed by a temper-
ature-sensitive mutant of v-Rel, undergo apoptosis oncedata), raising the possibility of a much wider role for
this novel signaling pathway in modulation of cytokine they are shifted to the nonpermissive temperature, sug-
gesting that v-Rel expression protected from apoptosisstimulation of multiple cell types. Lastly, these results
supportan pRb-independent mechanism for the TGFb1- (White et al., 1995). Recently, RelA-deficient mice dis-
played embryonic lethality within 14 days of gestation,mediated drop in the rate of c-myc gene transcription,
since the decline in c-myc expression precedes by 7–9 which was accompanied by massive liver degeneration
due to apoptosis of hepatocytes (Beg et al., 1995). Inhr the appearance of active hypophosphorylated pRb
(Fischer et al., 1994). this latter case, however, it was not established whether
the absence of RelA expression was directly involvedThe decline in Rel factor binding following TGFb1
treatment correlated with an increase in IkBa expres- in the cellular death. Interestingly, TGFb1 is also capable
of inducing apoptosis in liver cells (Oberhammer et al.,sion. However, given the complexity of the regulation
of NF-kB/Rel activity, the possible involvement of other 1992).
mechanisms leading to the decreased binding of these
factors cannot be ruled out. The induction of IkBa by CD40-Mediated Down-Regulation of IkBa
TGFb1 was completely abrogated by costimulation with Surface engagement of CD40, a member of the TNFR
the protein synthesis inhibitor CHX (Figure 2B; data not superfamily (Smith et al., 1994), overrides the anti-immu-
shown), suggesting that IkBa up-regulation by TGFb1 noglobulin and TGFb1-mediated growth arrest of WEHI
requires de novo protein synthesis. These findings sug- 231 cells (Santos-Argumedo et al., 1994). Moreover,
gest that activation of IkBa is not a result of a direct CD40L costimulation protected mature B and WEHI 231
effect of TGFb1. Of potential relevance is the recent cells from anti-immunoglobulin–mediated apoptosis
finding that TGFb receptor type I can interact, in vitro, (Tsubata et al., 1993). CD40L similarly rescues WEHI
with the immunophilin protein FKBP12 (Wang et al., 231 from cellular death induced by TGFb1. This effect
1994); FKBP12 is capable of modulating the calcineurin- correlates with downmodulation of cytosolic expression
dependent pathway and therefore NF-kB/Rel expres- of IkBa gene. The mechanism by which engagement of
sion (Schreiber, 1991). Two groups have recently dem- CD40 leads to IkBa down-regulation is currently under
onstrated that glucocorticoids (GC) can induce IkBa investigation. Recently, a new class of proteins with a
synthesis and thus interfere with NF-kB/Rel activity (Au- common functional domain, termed TNF receptor–
phan et al., 1995; Scheinman et al., 1995a, 1995b), sug- associated factors (TRAF), capable of interacting with
gesting that GC immunosuppressant activity is, in part, members of the TNFR superfamily, has been identified
attributable to Rel downmodulation. In this case, how- (Rothe et al., 1994). In particular, thecytoplasmic domain
ever, a direct effect of GC on IkBa gene transcription of CD40 has been found tobe associated with two mem-
was indicated. Dexamethasone treatment of HeLa cells bers of the TRAF family, TRAF2 (Rothe et al., 1995), and
increased IkBa gene transcription within 15 min, and CRAF or TRAF 3 (Cheng et al., 1995), responsible for
cotreatment with CHX resulted in the superinduction the downstream signaling that results in NF-kB/Rel acti-
of IkBa expression. IkBb expression was found to be vation. The results presented here suggest the hypothe-
unchanged in response to GC treatment of HeLa cells, sis that TRAF species are involved in the signaling by
similar to the effects of TGFb1 in B cell lymphomas. CD40 that results in the down-regulation of IkBa gene
expression.
NF-kB/Rel and Apoptosis Experimental Procedures
Recently, we demonstrated that anti-immunoglobulin
receptor–mediated apoptosis of WEHI 231 cells is ac- Cell Culture, Treatment, and Transfection Conditions
WEHI 231 and CH33 cells were maintained in Dulbecco’s modifiedcompanied by down-regulation of NF-kB/Rel activity
Eagles medium (DMEM), supplemented as described previously(Lee et al., 1995). More recently, we have found that
(Lee et al., 1995). For treatment, cells were incubated for the indi-treatment with various inhibitors of NF-kB/Rel species
cated periods of time with 2 ng/ml TGFb1 (R and D Systems, Minne-
such as N-tosyl-L-phenylalanine chloromethyl ketone apolis, Minnesota or Austral Biological, San Ramon, California) dis-
(TPCK) and pyrrolidinethiocarbamate (PDTC) promotes solved in 0.1% carrier BSA or 2 ng/ml BSA as control. CD40L, which
was prepared as a soluble fusion protein as described previouslyapoptosis in normal murine splenic B lymphocytes and
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